The combination of mitomycin C, methyl-CCNU and 5-fluorouracil produced no objective tumor regressions in 25 evaluable patients with metastatic colorectal carcinoma. Patients who achieved stable disease survived significantly longer than patients who had progressive disease. This difference appeared to be more probably related to pre-treatment characteristics of the patients than caused by treatment. Serial CEA determinations revealed a parallel relationship with tumor behavior in 17 of 19 patients.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/BF00578560 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Effect of Immunosuppressive Agents on Hepatocyte Apoptosis Post-Liver Transplantation.
PLoS One
May 2016
Department of Medicine, The University of Melbourne, Austin Hospital, Heidelberg, VIC, Australia; Department of Infectious Diseases, Austin Hospital, Heidelberg, VIC, Australia; Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, VIC, Australia.
Article Synopsis
- Immunosuppressants, commonly used after liver transplants to prevent organ rejection, may have unknown negative effects on liver cells (hepatocytes), potentially promoting cell death and inflammation.
- A study analyzed liver tissue from post-transplant patients and performed experiments on primary mouse hepatocytes to assess this issue, revealing significant increases in apoptosis markers in transplant patients.
- While common drugs like cyclosporine and tacrolimus alone did not enhance cell death, their combination with MMF significantly increased hepatocyte apoptosis, suggesting these drug regimens could contribute to liver fibrosis in some transplant recipients.
Chemotherapy for patients with gastric cancer after complete resection: a network meta-analysis.
World J Gastroenterol
January 2014
Ya-Wu Zhang, Yu-Long Zhang, Hui Pan, Feng-Xian Wei, You-Cheng Zhang, Yuan Shao, Wei Han, Hai-Peng Liu, Zhe-Yuan Wang, Sun-Hu Yang, Department of General Surgery, Lanzhou University Second Hospital, Lanzhou 730030, Gansu Province, China.
Aim: To conduct a network meta-analysis to evaluate the effectiveness of different chemotherapy regimens for patients with gastric cancer.
Methods: PubMed (1966-2011.12), the Cochrane Library (2011 Issue 2) and EMBASE (1974-2011.
[Secondary membranous nephropathy: The topics of membranous lupus nephritis].
Nihon Jinzo Gakkai Shi
November 2011
ANCA vasculitis: time for a change in treatment paradigm? Not yet.
Rheumatology (Oxford)
June 2011
Department of Rheumatology, Norfolk and Norwich University Foundation NHS Trust, Norfolk, UK.
The ANCA-associated vasculitides (AAVs) are conventionally treated with a strategy of remission induction followed by maintenance therapy using glucocorticoids combined with CYC during induction and AZA for maintenance. Recently, several randomized controlled trials have been published that question whether these drugs should remain those of choice. B-cell depletion using rituximab is at least as effective as CYC for remission induction in newly presenting patients, but long-term efficacy, safety and cost-effectiveness data are awaited, and thus rituximab should be reserved for patients at high risk of infertility.
View Article and Find Full Text PDFSurveillance renal transplant biopsies and subclinical rejection at three months post-transplant in pediatric recipients.
Pediatr Transplant
August 2007
Department of Pediatrics, Division of Nephrology, Emory University, 2015 Uppergate Drive, Atlanta, GA 30322, USA.
Unlabelled: Subclinical acute rejection (SCR) has been increasingly recognized in adult renal transplant recipients with the advent of surveillance biopsies. However, in children, surveillance biopsies are not routinely performed at most centers. Therefore, the incidence, predisposing factors, treatment, and clinical outcomes of SCR remain unclear in children.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!